Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.72%91.72B | 2.45%93.33B | -0.92%24.68B | 3.23%23.68B | -2.38%22.87B | 11.46%22.11B | 19.45%91.11B | 29.74%24.91B | 25.01%22.94B | 27.35%23.43B |
| Cost of revenue | -3.59%77.89B | 1.18%80.8B | -3.69%21.02B | 3.85%20.72B | -3.81%19.72B | 10.00%19.34B | 22.58%79.86B | 29.27%21.83B | 25.96%19.95B | 32.90%20.5B |
| Gross profit | 10.33%13.83B | 11.45%12.54B | 18.73%3.65B | -0.84%2.96B | 7.59%3.15B | 22.80%2.77B | 1.13%11.25B | 33.16%3.08B | 19.04%2.99B | -1.48%2.93B |
| Operating expense | -6.06%11.56B | -1.04%12.31B | 33.50%3.01B | -11.71%3.02B | -9.43%3.1B | -4.79%3.18B | 16.98%12.44B | -16.94%2.25B | 18.24%3.42B | 42.51%3.43B |
| Operating profit | 887.39%2.27B | 119.38%230M | -21.58%647M | 87.41%-54M | 108.78%44M | 62.38%-407M | -341.26%-1.19B | 306.25%825M | -12.89%-429M | -188.67%-501M |
| Net non-operating interest income (expenses) | -46.29%-768M | -40.37%-525M | -72.41%-150M | -2.48%-124M | -19.63%-128M | -108.47%-123M | -82.44%-374M | -85.11%-87M | -120.00%-121M | -94.55%-107M |
| Non-operating interest income | 61.29%50M | 138.46%31M | 0.00%5M | 325.00%17M | 400.00%5M | 33.33%4M | -27.78%13M | 66.67%5M | 0.00%4M | -75.00%1M |
| Non-operating interest expense | 47.12%818M | 43.67%556M | 68.48%155M | 12.80%141M | 23.15%133M | 104.84%127M | 73.54%387M | 84.00%92M | 111.86%125M | 83.05%108M |
| Net investment income | -109.72%-145M | 80.85%1.49B | 179.08%907M | 54.64%-499M | -54.95%282M | -17.66%802M | -15.47%825M | -54.74%325M | -545.34%-1.1B | 2,880.95%626M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 65.45%-76M | -272.88%-220M | -59M | |||||||
| Income from associates and other participating interests | 73.68%165M | 58.33%95M | -371.43%-19M | 766.67%40M | -22.00%39M | 288.89%35M | -17.81%60M | -70.83%7M | -115.00%-6M | 2,600.00%50M |
| Special income (charges) | 100.45%8M | -6,551.85%-1.8B | -1,793.94%-625M | -962M | -1,800.00%-190M | -218.75%-19M | -117.88%-27M | 91.22%-33M | 0 | 79.17%-10M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | ---- | ---- | ---- | ---- | ---252M | ---- | ---- | ---- |
| Less:Other special charges | -114.86%-258M | 638.72%1.74B | 134.44%565M | --962M | 1,800.00%190M | 218.75%19M | 255.63%235M | -35.90%241M | --0 | -79.17%10M |
| Less:Write off | 316.67%250M | 36.36%60M | ---- | ---- | ---- | ---- | --44M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -375.00%-55M | 114.18%20M | -38.18%68M | 101.68%2M | 77.38%-19M | 35.42%-31M | -101.43%-141M | 816.67%110M | -120.37%-119M | -500.00%-84M |
| Income before tax | 298.44%1.4B | 22.30%-704M | -43.77%609M | 10.08%-1.6B | 204.17%25M | 237.04%259M | -163.98%-906M | 1,647.14%1.08B | -13,761.54%-1.78B | -105.13%-24M |
| Income tax | -17.48%963M | 652.90%1.17B | 528.16%647M | 117.89%56M | -34.65%132M | 103.68%332M | 6.16%155M | 117.00%103M | -225.20%-313M | 3.06%202M |
| Net income | 123.20%434M | -76.34%-1.87B | -103.88%-38M | -13.13%-1.65B | 52.65%-107M | 79.60%-72M | -183.54%-1.06B | 82.84%980M | -516.88%-1.46B | -183.09%-226M |
| Net income continuous operations | 123.20%434M | -76.34%-1.87B | -103.88%-38M | -12.99%-1.65B | 52.65%-107M | 79.26%-73M | -183.54%-1.06B | 82.84%980M | -517.30%-1.46B | -183.09%-226M |
| Noncontrolling interests | -12.00%22M | 92.31%25M | -40.00%3M | 75.00%14M | 200.00%3M | 600.00%5M | 181.25%13M | 66.67%5M | 188.89%8M | 110.00%1M |
| Net income attributable to the company | 121.67%411M | -76.47%-1.9B | -104.31%-42M | -13.48%-1.67B | 51.53%-111M | 78.06%-77M | -183.53%-1.08B | 82.40%974M | -544.30%-1.47B | -181.21%-229M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 121.67%411M | -76.47%-1.9B | -104.31%-42M | -13.48%-1.67B | 51.53%-111M | 78.06%-77M | -183.53%-1.08B | 82.40%974M | -544.30%-1.47B | -181.21%-229M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 121.69%49.14 | -62.41%-226.59 | -103.70%-4.94 | -2.56%-199.13 | 57.05%-13.25 | 80.76%-9.27 | -177.93%-139.52 | 81.19%133.68 | -483.06%-194.16 | -182.51%-30.85 |
| Diluted earnings per share | 121.69%49.14 | -62.41%-226.59 | -104.31%-5.0162 | -2.56%-199.13 | 57.65%-13.2565 | 80.76%-9.27 | -177.93%-139.52 | 58.97%116.3228 | -483.06%-194.16 | -183.72%-31.3029 |
| Dividend per share | 100.00%25 | -50.00%12.5 | 0.00%12.5 | 0 | 0 | 0 | 0.00%25 | 0.00%12.5 | 0 | 0.00%12.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |